AKT1 and type 2 diabetes mellitus: Similarly, muscle biopsies that were obtained from T2DM patients that were treated with either rosiglitazone or pioglitazone showed increased insulin-stimulated IRS-1 tyrosine phosphorylation, IRS-1-associated PI3-kinase activity, and AKT/PKB activity [109,110].